J P Dyke1, D Sondhi2, H U Voss3, K Yohay4, C Hollmann2, D Mancenido2, S M Kaminsky2, L A Heier3, K D Rudser5, B Kosofsky4, B J Casey6, R G Crystal2, D Ballon7. 1. From the Departments of Radiology (J.P.D., H.U.V., L.A.H., D.B.) jpd2001@med.cornell.edu. 2. Genetic Medicine (D.S., C.H., D.M., S.M.K., R.G.C., D.B.). 3. From the Departments of Radiology (J.P.D., H.U.V., L.A.H., D.B.). 4. Pediatrics (K.Y., B.K.). 5. Division of Biostatistics (K.D.R.), Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota. 6. Psychiatry (B.J.C.), Weill Cornell Medical College, New York, New York. 7. From the Departments of Radiology (J.P.D., H.U.V., L.A.H., D.B.) Genetic Medicine (D.S., C.H., D.M., S.M.K., R.G.C., D.B.).
Abstract
BACKGROUND AND PURPOSE: Late infantile neuronal ceroid lipofuscinosis (CLN2 disease) is a uniformly fatal lysosomal storage disease resulting from mutations in the CLN2 gene. Our hypothesis was that regional analysis of cortical brain degeneration may identify brain regions that are affected earliest and most severely by the disease. MATERIALS AND METHODS: Fifty-two high-resolution 3T MR imaging datasets were prospectively acquired on 38 subjects with CLN2. A retrospective cohort of 52 disease-free children served as a control population. The FreeSurfer software suite was used for calculation of cortical thickness. RESULTS: An increased rate of global cortical thinning in CLN2 versus control subjects was the primary finding in this study. Three distinct patterns were observed across brain regions. In the first, subjects with CLN2 exhibited differing rates of cortical thinning versus age. This was true in 22 and 26 of 34 regions in the left and right hemispheres, respectively, and was also clearly discernable when considering brain lobes as a whole and Brodmann regions. The second pattern exhibited a difference in thickness from healthy controls but with no discernable change with age (9 left hemispheres, 5 right hemispheres). In the third pattern, there was no difference in either the rate of cortical thinning or the mean cortical thickness between groups (3 left hemispheres, 3 right hemispheres). CONCLUSIONS: This study demonstrates that CLN2 causes differential rates of degeneration across the brain. Anatomic and functional regions that degenerate sooner and more severely than others compared with those in healthy controls may offer targets for directed therapies. The information gained may also provide neurobiologic insights regarding the mechanisms underlying disease progression.
BACKGROUND AND PURPOSE: Late infantile neuronal ceroid lipofuscinosis (CLN2 disease) is a uniformly fatal lysosomal storage disease resulting from mutations in the CLN2 gene. Our hypothesis was that regional analysis of cortical brain degeneration may identify brain regions that are affected earliest and most severely by the disease. MATERIALS AND METHODS: Fifty-two high-resolution 3T MR imaging datasets were prospectively acquired on 38 subjects with CLN2. A retrospective cohort of 52 disease-free children served as a control population. The FreeSurfer software suite was used for calculation of cortical thickness. RESULTS: An increased rate of global cortical thinning in CLN2 versus control subjects was the primary finding in this study. Three distinct patterns were observed across brain regions. In the first, subjects with CLN2 exhibited differing rates of cortical thinning versus age. This was true in 22 and 26 of 34 regions in the left and right hemispheres, respectively, and was also clearly discernable when considering brain lobes as a whole and Brodmann regions. The second pattern exhibited a difference in thickness from healthy controls but with no discernable change with age (9 left hemispheres, 5 right hemispheres). In the third pattern, there was no difference in either the rate of cortical thinning or the mean cortical thickness between groups (3 left hemispheres, 3 right hemispheres). CONCLUSIONS: This study demonstrates that CLN2 causes differential rates of degeneration across the brain. Anatomic and functional regions that degenerate sooner and more severely than others compared with those in healthy controls may offer targets for directed therapies. The information gained may also provide neurobiologic insights regarding the mechanisms underlying disease progression.
Authors: J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport Journal: Nat Neurosci Date: 1999-10 Impact factor: 24.884
Authors: S Worgall; M V Kekatpure; L Heier; D Ballon; J P Dyke; D Shungu; X Mao; B Kosofsky; M G Kaplitt; M M Souweidane; D Sondhi; N R Hackett; C Hollmann; R G Crystal Journal: Neurology Date: 2007-08-07 Impact factor: 9.910
Authors: Matthew J Clarkson; M Jorge Cardoso; Gerard R Ridgway; Marc Modat; Kelvin K Leung; Jonathan D Rohrer; Nick C Fox; Sébastien Ourselin Journal: Neuroimage Date: 2011-05-26 Impact factor: 6.556
Authors: J P Dyke; D Sondhi; H U Voss; D C Shungu; X Mao; K Yohay; S Worgall; N R Hackett; C Hollmann; M E Yeotsas; A L Jeong; B Van de Graaf; I Cao; S M Kaminsky; L A Heier; K D Rudser; M M Souweidane; M G Kaplitt; B Kosofsky; R G Crystal; D Ballon Journal: AJNR Am J Neuroradiol Date: 2012-10-04 Impact factor: 3.825
Authors: A Biswas; P Krishnan; A Amirabadi; S Blaser; S Mercimek-Andrews; M Shroff Journal: AJNR Am J Neuroradiol Date: 2020-08-27 Impact factor: 3.825
Authors: Jonathan B Rosenberg; Alvin Chen; Stephen M Kaminsky; Ronald G Crystal; Dolan Sondhi Journal: Expert Opin Orphan Drugs Date: 2019-11-27 Impact factor: 0.694
Authors: Dolan Sondhi; Stephen M Kaminsky; Neil R Hackett; Odelya E Pagovich; Jonathan B Rosenberg; Bishnu P De; Alvin Chen; Benjamin Van de Graaf; Jason G Mezey; Grace W Mammen; Denesy Mancenido; Fang Xu; Barry Kosofsky; Kaleb Yohay; Stefan Worgall; Robert J Kaner; Mark Souwedaine; Bruce M Greenwald; Michael Kaplitt; Jonathan P Dyke; Douglas J Ballon; Linda A Heier; Szilard Kiss; Ronald G Crystal Journal: Sci Transl Med Date: 2020-12-02 Impact factor: 17.956
Authors: Katharina N Russell; Nadia L Mitchell; Nigel G Anderson; Craig R Bunt; Martin P Wellby; Tracy R Melzer; Graham K Barrell; David N Palmer Journal: Brain Behav Date: 2018-08-23 Impact factor: 2.708
Authors: Jan-Niklas Hochstein; A Schulz; M Nickel; S Lezius; M Grosser; J Fiehler; J Sedlacik; U Löbel Journal: Neuroradiology Date: 2022-06-14 Impact factor: 2.995